Literature DB >> 21212056

Molecular cloning and functional characterization of two novel membrane fusion proteins in conferring antimicrobial resistance in Acinetobacter baumannii.

Vijaya Bharathi Srinivasan1, Govindan Rajamohan, Preeti Pancholi, Mario Marcon, Wondwossen A Gebreyes.   

Abstract

OBJECTIVES: The aim of this study was to elucidate the role of two novel membrane fusion proteins (MFPs) in the susceptibility of Acinetobacter baumannii to antimicrobial agents.
METHODS: The genome sequence of A. baumannii ATCC 17978 contains two open reading frames (ORFs) annotated as AdeT in the NCBI genome database. Both the putative efflux genes display >30% similarity to known MFPs. The antimicrobial susceptibility profiles of Escherichia coli KAM32 cells carrying the genes were monitored by the broth dilution method. Different efflux pump inhibitors were used for fluorimetric efflux assays. The functions of putative ORFs were confirmed in A. baumannii by insertional inactivation and complementation.
RESULTS: E. coli cells carrying the ORFs had decreased susceptibility to antibiotics, disinfectants, dyes and detergents, with enhanced efflux activity. Inactivation of the ORFs and further characterization in A. baumannii confirmed its role in antimicrobial resistance by active efflux.
CONCLUSIONS: This report describes the functions of novel resistance determinants, members of the MFP family, for the first time in A. baumannii.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212056     DOI: 10.1093/jac/dkq469

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Functional Characterization of AbaQ, a Novel Efflux Pump Mediating Quinolone Resistance in Acinetobacter baumannii.

Authors:  María Pérez-Varela; Jordi Corral; Jesús Aranda; Jordi Barbé
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

2.  Comparative Phosphoproteomics Reveals the Role of AmpC β-lactamase Phosphorylation in the Clinical Imipenem-resistant Strain Acinetobacter baumannii SK17.

Authors:  Juo-Hsin Lai; Jhih-Tian Yang; Jeffy Chern; Te-Li Chen; Wan-Ling Wu; Jiahn-Haur Liao; Shih-Feng Tsai; Suh-Yuen Liang; Chi-Chi Chou; Shih-Hsiung Wu
Journal:  Mol Cell Proteomics       Date:  2015-10-23       Impact factor: 5.911

3.  An outbreak of blaOXA-51-like- and blaOXA-66-positive Acinetobacter baumannii ST208 in the emergency intensive care unit.

Authors:  Satomi Asai; Kazuo Umezawa; Hideo Iwashita; Toshio Ohshima; Maya Ohashi; Mika Sasaki; Hideki Hayashi; Mari Matsui; Keigo Shibayama; Sadaki Inokuchi; Hayato Miyachi
Journal:  J Med Microbiol       Date:  2014-08-20       Impact factor: 2.472

4.  Effect of membrane fusion protein AdeT1 on the antimicrobial resistance of Escherichia coli.

Authors:  Victoria L Barlow; Shu-Jung Lai; Chia-Yu Chen; Cheng-Han Tsai; Shih-Hsiung Wu; Yu-Hsuan Tsai
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

5.  The Acinetobacter baumannii Two-Component System AdeRS Regulates Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner.

Authors:  Grace E Richmond; Laura P Evans; Michele J Anderson; Matthew E Wand; Laura C Bonney; Alasdair Ivens; Kim Lee Chua; Mark A Webber; J Mark Sutton; Marnie L Peterson; Laura J V Piddock
Journal:  mBio       Date:  2016-04-19       Impact factor: 7.867

6.  Molecular Characterization of Reduced Susceptibility to Biocides in Clinical Isolates of Acinetobacter baumannii.

Authors:  Fei Lin; Ying Xu; Yaowen Chang; Chao Liu; Xu Jia; Baodong Ling
Journal:  Front Microbiol       Date:  2017-09-26       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.